Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 712572 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Printer Friendly
PDF Brochure
ElectronicAdd to Basket
Live Chat Live Help Software for Website

Blockbuster Drugs: A 2005-2014 Forecast

Decision Resources, Inc., Dec 2005, Pages: 79


  Description  
   Table of Contents   
   Summary   
   Companies Mentioned   
    
     
  Enquire before Buying   
  Send to a Friend   

Blockbuster drugs--drugs with annual sales topping $1 billion--accounted for approximately 30% of the pharmaceutical industry's total sales in 2004. In the next several years, patent expiries on many blockbusters will fundamentally alter the sales outlook for leading pharmaceutical companies. What strategies will companies pursue to replace sales lost to generics competition? Pursuit of new blockbusters is one approach, though the shift taking place in the therapeutic areas ripe for blockbuster development means that some companies must adjust their core competencies.

In this report, we identify drugs that we believe will achieve blockbuster status during a 2005-2014 forecast period, presenting them by therapeutic area and describing each drug's mechanism of action, performance in clinical trials, strengths and weaknesses, and competitive opportunities and threats. We also point to other drugs that are contenders for blockbuster status.



Customers who bought this item also bought

SPECIAL REPORT: Blockbusters Then and Now - Trends for Billion-Dollar Drugs

The Global Pain Therapeutics Market, 4th Edition: Market Trends & R&D Insights

DPP IV Inhibitors - Global Strategic Business Report

Diabetes Market Forecast to 2015

Emerging Pharmaceutical Blockbusters: 2010’s Billion-Dollar Babies

Emerging Blockbusters: 2009's Most Promising Drugs and the Future of the Blockbuster Model

Successes and Failures for Avastin (Bevacizumab) mean Mixed News for the Blockbuster Drug in the Oncology Therapeutics Market

Emerging Markets for Clinical Trials in India - Favorable Regulatory Environment and Cost Effectiveness Will Accelerate the Number of Clinical Trials

The Billion-Dollar Question: Which Emerging Agents Have Blockbuster Potential

The Future of eClinical Trial Solutions – Market Forecasts to 2015, Competitive Benchmarking and Case Studies



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds